Structure Therapeutics Inc.

GPCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001963664-26-000002
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Ma Yingli (CHIEF TECHNOLOGY OFFICER)
SEC Filing link

Summary

Type

Sell

Net shares

-11,313

% of shares

-9.53%

Amount (USD)

$237,459

Insider confidence score

22.5 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-11,313.0

Price per Share

$20.99

Amount (USD)

$237,459.87

Acquired/Disposed

Disposed

Shares Owned Before

118,704.0

Shares Owned After

107,391.0

Filing's footnotes

1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

2. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.